Drug
Luvometinib Anlotinib
Luvometinib Anlotinib: highest development phase Phase 2, developed by Shanghai Fosun Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| luvometinib + anlotinib NCT07562581 | Phase 2 | Non-small Cell Lung Caner |
Latest
No recent events.
Follow Luvometinib Anlotinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.